Advertisement
Screener

ZYTO CORP Form 8-K: Current report

ZYTO CORP Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2012-11-30: Form 8-K; Period of report 2012-11-26; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
  • 2012-04-09: Form 8-K; Period of report 2012-04-05; Description 7.01 Regulation FD Disclosure; Details 7.01.
  • 2012-01-23: Form 8-K; Period of report 2012-01-17; Description 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 7.01.
  • 2011-12-12: Form 8-K; Period of report 2011-12-06; Description 5.07 Submission of Matters to a Vote of Security Holders; 6.02 Item 6.02; Details 5.07.
FiledFormPeriod of reportDescriptionDetailsDocument
2012-11-308-K2012-11-265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On November 26, 2012, ZYTO Corp (the "Company") terminated Brian E. Halladay as the Company's Chief Financial Officer.rrd361683.htm
2012-04-098-K2012-04-057.01 Regulation FD Disclosure7.01 On Thursday, April 5, 2012, ZYTO Corp, a Delaware corporation (the “Company” or “ZYTO”), hosted a web-based seminar, or webinar (the “Webinar”), during which Dr. Vaughn R Cook, the founder and CEO of ZYTO discussed the Company’s 2011 results as well as upcoming events.zytc8k20120405.htm
2012-01-238-K2012-01-177.01 Regulation FD Disclosure; 8.01 Other Events7.01 On January 23, 2012, the Company issued a press release announcing the grant of the Patent by the USPTO.
8.01 On January 23, 2012, ZYTO Corp (the “Company”) announced that it had received notice and confirmation from the United States Patent and Trademark Office (“USPTO”) stating that the Company’s patent application for “Methods and Devices for Analyzing and Comparing Physiological Parameter Measurements” (the “Patent”) was issued on January 17, 2012, and given Patent No. 8,099,159.
zyto8k20120117.htm
2011-12-128-K2011-12-065.07 Submission of Matters to a Vote of Security Holders; 6.02 Item 6.025.07 On December 6, 2011, ZYTO Corp, a Delaware corporation (the “Company” or “ZYTO”), held its 2011 Annual Meeting of Shareholders (the “Meeting”) at the offices of the Company in Lindon, Utah.zyto8k20111206.htm
2011-09-088-K2011-08-307.01 Regulation FD Disclosure; 8.01 Other Events7.01 On September 8, 2011, the Registrant issued a press release announcing the approval of the Notification by the FDA.
8.01 On August 30, 2011, ZYTO Corp (the “Registrant”) received notice from the US Food and Drug Administration (the “FDA”) that the Registrant’s Premarket Notification (the “Notification”), submitted pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act (the “Act”) had been approved.
zyto8k20110830.htm
2011-06-088-K2011-06-087.01 Regulation FD Disclosure7.01 On June 8, 2011, ZYTO Corp (the “Registrant”) issued a press release announcing the development of the ZYTO Sphere, a biocommunication tool that can be used with animals.zytc8k20110608.htm
2011-04-118-K2011-04-117.01 Regulation FD Disclosure7.01 On April 11, 2011, ZYTO Corp issued a press release announcing that the Financial Industry Regulatory Authority (FINRA) approved the application for ZYTO’s common stock to trade on the OTC Bulletin Board.zyto8k20110411.htm
2011-04-048-K2011-03-315.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure5.02 On March 31, 2011, the Board of Directors of ZYTO Corp (the “Company”) appointed Kami J. Howard to serve as the Company’s President and Chief Operating Officer.
7.01 On April 4, 2011, the Company issued a press release announcing the change in management positions.
zytc8k20110331.htm
2011-02-228-K2011-02-168.01 Other Events8.01 On February 22, 2011, ZYTO Corp. (the “Company”) issued a press release announcing that, in connection with the Company’s intention to uplist to the OTC Bulletin Board (the “OTCBB”), a market maker filed a Form 211 on the Company’s behalf with the Financial Industry Regulatory Authority (“FINRA”) on February 16, 2011.zytocorp8k20110222.htm
2011-02-088-K2011-02-048.01 Other Events8.01 On February 8, 2011, ZYTO Corp. (the “Company”) issued a press release announcing that the Securities and Exchange Commission has completed its review of the Company’s Registration Statement on Form 10.zytc8k20110204.htm
2011-02-018-K2011-01-281.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant1.01 Entry into a Material Definitive Agreement.
2.03 See Item 1.01, which is incorporated herein by reference.
zytc20110128.htm
2010-08-168-K2010-08-135.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On August 13, 2010, Goodwin Wang, a director, submitted an e-mail resignation to ZYTO Corp (the “Company”) in which he resigned from the Company’s Board of Directors, effective immediately.zytc8k20100813.htm